Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck & Co

Showing 8 posts of 53 posts found.

Emerging markets key for Merck’s long-term performance

May 13, 2010
Research and Development, Sales and Marketing Merck & Co, em

Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success …

News

Merck gains rights to cancer treatment

May 10, 2010
Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC

Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …

News

Pharma manufacturing news in brief

May 10, 2010
Manufacturing and Production American Peptide, DSM Biologics, Dutch CMO SynCo Bio Partners, KV Pharmaceutical, Merck & Co, manufacturing

This week’s round-up of pharmaceutical manufacturing news includes facility updates from KV Pharmaceutical, DSM Biologics, Merck & Co and American …

News
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …

Appointment

Nycomed partners with Merck on Daxas

April 26, 2010
Sales and Marketing Daxas, Merck & Co, Nycomed

Swiss firm Nycomed and Merck & Co have agreed to co-promote oral chronic obstructive pulmonary disease candidate Daxas in Europe. …

News

Merck appoints UK leadership team

January 26, 2010
MSD, Merck & Co, appointment

Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …

Appointment

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009
Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …

Appointment
Merck & Co building

Merck buys Avecia to boost biomanufacturing

December 21, 2009
Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026